arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

InfuSystem Holdings, Inc

INFU
$12.46 ▲ +0.56 (+4.71%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
67 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

InfuSystem Holdings, Inc shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $251.8M
Dividend Yield
Revenue Growth -3.0%
Op. Margin 4.7%
ROIC 1.5%
FCF / Share $0.04
Trailing P/E 249.2x
Price / Book 4.3x
FCF Yield 0.3%
Debt / Equity 0.33
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$33.68M
↓ -3.0%
Net Income Profit after all expenses
$1.02M
↓ -50.0%
Operating Margin Operating profit as % of sales
4.7%
↓ -54.0% 52th
FCF / Share Free cash flow per share
$0.04
↓ -48.5%
Long-Term Debt Long-term obligations
$19.65M
— +0.1%

Health Breakdown

Profitability
59
Returns
72
Financial Health
71
Cash Quality
93

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters